Financhill
Back

Applied Therapeutics Stock Predictions

Applied Therapeutics Stock Forecast

  • Is Applied Therapeutics Stock Undervalued?
    The current Applied Therapeutics [APLT] share price is $0.85. The Score for APLT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • APLT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Applied Therapeutics Stock Go Up Next Year?

Data Unavailable

Applied Therapeutics Stock Rating

Data Unavailable

Applied Therapeutics Stock Price History

Is APLT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
appliedtherapeutics.com

52-Week Data

52-Week High:
10.62
52-Week Low:
0.78

Prediction Charts

Market Cap:
99.1M
Price in USD:
0.85
Volume:
3M
Beta:
1.61

Technical Analysis

SMA50:
6.32
SMA100:
6.47
SMA200:
5.77
52-Wk Change:
-72.71%

Stock Predictions

  • Is Applied Therapeutics stock public?
    Yes, Applied Therapeutics is a publicly traded company.
  • What is the Applied Therapeutics stock quote today?
    The Applied Therapeutics stock price is 0.85 USD today.
  • How to buy Applied Therapeutics stock online?
    You can buy Applied Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 1.37 1.29 1.42 1.27
Dec-6 1.28 1.28 1.33 1.18
Dec-9 1.25 1.24 1.40 1.22
Dec-10 1.22 1.21 1.27 1.19
Dec-11 1.17 1.24 1.26 1.16
Dec-12 1.24 1.14 1.37 1.12
Dec-13 1.11 1.15 1.17 1.08
Dec-16 1.10 1.15 1.15 1.03
Dec-17 1.12 1.10 1.13 1.05
Dec-18 1.05 1.09 1.14 0.95
Dec-19 1.05 1.02 1.10 1.00
Dec-20 0.95 0.88 0.99 0.84
Dec-23 0.85 0.87 0.88 0.78
Dec-24 0.83 0.85 0.88 0.80

Applied Therapeutics Earnings

Data Unavailable

Applied Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.94 per share.

* Applied Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.